SCHEMBL19142373

SCHEMBL19142373

Fc1ccc(C2COCCN2)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 4/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ HTR2B P41595 1/20 0.42
▸ CSNK1D P48730 1/20 0.41
▸ CSNK1E P49674 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ OPRL1 P41146 9/20 0.39
▸ PRKACA P17612 1/20 0.36
▸ PRKACG P22612 1/20 0.36
▸ PRKACB P22694 1/20 0.36
▸ PIK3C3 Q8NEB9 1/20 0.36
▸ NISCH Q9Y2I1 1/20 0.34
▸ SLC6A2 P23975 3/20 0.33
▸ SLC6A3 Q01959 3/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HRH1 P35367 1/20 0.32
▸ NR1I2 O75469 1/20 0.32
▸ BRAF P15056 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31444529 0.84 HTR2A (0.40) SLC6A4HTR2AHTR2CHTR2BPRKACA
SCHEMBL25907627 0.81 KDM1A (0.41) HTR2AHTR2CCSNK1DCSNK1EKCNH2
SCHEMBL20319860 0.78 TAAR1 (0.38) SLC6A4HTR2AHTR2CHTR2BOPRL1
SCHEMBL25316221 0.76 MEN1 (0.44) SLC6A4HTR2AHTR2CHTR2BKCNH2
Hydrochloric Acid SCHEMBL31444535 0.76 HTR2A (0.39) HTR2AHTR2CHTR2BOPRL1PRKACA
SCHEMBL28519635 0.76 MEN1 (0.44) SLC6A4HTR2AHTR2CHTR2BKCNH2
SCHEMBL31444556 0.76 PRKACA (0.36) CSNK1DCSNK1EKCNH2OPRL1PRKACA
SCHEMBL28785154 0.75 PRKACA (0.52) HTR2AHTR2CHTR2BCSNK1DCSNK1E
SCHEMBL432870 0.75 PRKACA (0.52) HTR2AHTR2CHTR2BCSNK1DCSNK1E
SCHEMBL31444311 0.75 HTR2A (0.41) SLC6A4HTR2AHTR2CHTR2BKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072451-A1 RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES VIVIDION THERAPEUTICS, INC. (US) 2025-04-03 — — WO disclosed
US-11759760-B2 Apparatus and process for the automated chemical synthesis of compounds ETH ZURICH (CH) 2023-09-19 — — US disclosed
US-11759760-B2 Apparatus and process for the automated chemical synthesis of compounds ETH ZURICH (CH) 2023-09-19 — — US disclosed
US-20230072608-A1 Apparatus and Process for the Automated Chemical Synthesis of Compounds ETH ZURICH (CH) 2023-03-09 — — US disclosed
US-20190209995-A1 Apparatus and Process for the Automated Chemical Synthesis of Compounds ETH ZURICH (CH) 2019-07-11 — — US disclosed
WO-2018116285-A1 SUBSTITUTED MORPHOLINE DERIVATIVES AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2018-06-28 — — WO disclosed
EP-3192583-A1 APPARATUS AND PROCESS FOR THE AUTOMATED CHEMICAL SYNTHESIS OF COMPOUNDS ETH Zurich (CH) 2017-07-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190209995-A1 Apparatus and Process for the Automated Chemical Synthesis of Compounds SQLE, FAH, ACACB SLC6A4 3280/4885HTR2A 2911/4885HTR2C 1579/4885
US-11759760-B2 Apparatus and process for the automated chemical synthesis of compounds SQLE, DCXR, FAH SLC6A4 3332/4885HTR2A 3754/4885HTR2C 2477/4885
US-20230072608-A1 Apparatus and Process for the Automated Chemical Synthesis of Compounds DCXR, SAMM50, AMD1 SLC6A4 3165/4885HTR2A 2954/4885HTR2C 2111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback